Stock listing

NASDAQ:PRTK Paratek Pharmaceuticals Inc Stock

Follow Paratek Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PRTK

$2.23 USD

Close on Sep 29, 2023 · No longer trades

Feb 2, 2009 to last close -50.4% · monthly closes, Feb 2, 2009 – Sep 29, 2023
Lowest – highest close
$1.37 – $208.96 USDSince Feb 2, 2009 · lowest Mar 20, 2023 · highest Jul 1, 2014

Delisted NASDAQ:PRTK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PRTK
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Paratek Pharmaceuticals Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest May 9, 2023
Decks
25 decks · latest Feb 24, 2021

Events

Open Events

Decks

DeckKindSlidesDate
FY2020 Earnings PresentationEarnings31 slidesFeb 24, 2021
FY2019 Earnings PresentationEarnings23 slidesFeb 25, 2020
FY2018 Earnings PresentationEarnings24 slidesFeb 27, 2019
Investor Presentation (January 2019)Investor deck45 slidesJan 4, 2019
Q3 2018 Earnings PresentationEarnings20 slidesNov 6, 2018
Investor Day (October 2018)Investor day31 slidesOct 23, 2018
Investor Presentation (January 2018)Investor deck39 slidesJan 5, 2018
Investor Presentation (January 2017)Investor deck48 slidesJan 9, 2017
Investor Presentation (June 2016)Investor deck12 slidesJun 20, 2016
Transcept Pharmaceuticals — Merger or Acquisition (July 2014)Merger or acquisition13 slidesJul 3, 2014
All 25 decks
DeckKindSlidesDate
Transcept Pharmaceuticals — Investor Presentation (September 2013)Investor deck27 slidesSep 25, 2013
Transcept Pharmaceuticals — Investor Presentation (January 2013)Investor deck19 slidesJan 7, 2013
Transcept Pharmaceuticals — Investor Presentation (July 2012)Investor deck24 slidesJul 11, 2012
Transcept Pharmaceuticals — Investor Presentation (April 2012)Investor deck22 slidesApr 3, 2012
Transcept Pharmaceuticals — Investor Presentation (March 2012)Investor deck23 slidesMar 13, 2012
Transcept Pharmaceuticals — Investor Presentation (September 2011)Investor deck29 slidesSep 19, 2011
Transcept Pharmaceuticals — Investor Presentation (May 2011)Investor deck54 slidesMay 24, 2011
Transcept Pharmaceuticals — Investor Presentation (February 2011)Investor deck34 slidesFeb 7, 2011
Transcept Pharmaceuticals — Investor Presentation (January 2011)Investor deck34 slidesJan 26, 2011
Transcept Pharmaceuticals — Investor Presentation (January 2011)Investor deck32 slidesJan 10, 2011
Transcept Pharmaceuticals — Investor Presentation (August 2010)Investor deck50 slidesAug 3, 2010
Transcept Pharmaceuticals — Investor Presentation (June 2010)Investor deck31 slidesJun 8, 2010
Transcept Pharmaceuticals — Investor Presentation (April 2010)Investor deck25 slidesApr 27, 2010
Transcept Pharmaceuticals — Technical Presentation (April 2010)Technical23 slidesApr 8, 2010
Novacea — Merger or Acquisition (September 2008)Merger or acquisition32 slidesSep 2, 2008

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Peter Walker
Other companies: Zosano Pharma Corp (Director · May 4, 2016 – Jun 25, 2020 · Past); Renovis Inc (Director · Oct 2, 2007 – May 2, 2008 · Past); Affymax Inc (Director · May 31, 2007 – Aug 28, 2013 · Past); Geron Corporation (Director · May 23, 2007 – Jan 30, 2009 · Past)
Director · May 9, 2007 – Feb 2, 2011 · Past
Doug Pagán
Other companies: Kailera Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 16, 2026); Dicerna Pharmaceuticals Inc (Chief Financial Officer · May 26, 2020 – Dec 28, 2021 · Past); Alaunos Therapeutics, Inc. (Director · Sep 18, 2018 – Dec 31, 2019 · Past)
Chief Financial Officer · Dec 18, 2014 – Apr 5, 2019 · Past
Minnie Baylor-Henry
Other companies: Apyx Medical Corporation (Director · Since at least Aug 11, 2022); Scpharmaceuticals Inc (Director · Since at least Jun 14, 2022); Lantheus Holdings, Inc. (Director · Since at least May 6, 2022)
Director · Feb 8, 2023 – Sep 21, 2023 · Past
Thomas John Dietz
Other companies: Cypherpunk Technologies Inc. (Director · Since at least Apr 18, 2018); Eiger Biopharmaceuticals Inc (Director · Mar 14, 2018 – Mar 1, 2023 · Past)
Director · Feb 5, 2018 – Sep 21, 2023 · Past
Timothy R Franson
Other companies: Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2023 · Past); Myrexis Inc (Director · Nov 11, 2010 – Dec 8, 2011 · Past)
Director · Jul 21, 2015 – Sep 21, 2023 · Past
Joseph T Kennedy
Other companies: Amarin Corporation plc (General Counsel · Dec 16, 2011 – Jul 30, 2021 · Past)
VP and General Counsel · Nov 23, 2011 – Dec 1, 2011 · Past
William M Haskel
Other companies: Cambrex Corporation (Senior Vice President · Oct 24, 2012 – Nov 13, 2014 · Past)
CLO, General Counsel & Sec. · Jun 29, 2015 – Sep 21, 2023 · Past
Adam WoodrowPresident & Chief Commercial · Feb 2, 2017 – Sep 21, 2023 · Past
Rolf K HoffmannDirector · Feb 19, 2020 – Sep 21, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Paratek Pharmaceuticals Inc.